International Health
Specialties
Developmental Therapeutics
The Northwestern Medicine Developmental Therapeutics works to accelerate the translation of preclinical science breakthroughs so as to develop better therapies for patients. Developmental Therapeutics is a broad area of study that includes basic research aimed at finding new targets for anticancer agents, preclinical testing of new drugs or cell and immune therapies for cancer treatment, and clinical trials to test new agents in people. New approaches are being used to prevent cancer, better predict its causes and improve its treatment. The Northwestern Medicine Developmental Therapeutics Institute offers patients the most advanced clinical trial and treatment options available. Our ability to call upon the world-class resources of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, the research and medical expertise of the Northwestern University Feinberg School of Medicine and Northwestern Medical Group, and the preeminent healthcare facilities of Northwestern Memorial Hospital allows the Institute to provide patients with the best possible care. Conditions and Treatments Our main focus is to bring new treatments and therapies to our patients as efficiently, safely and quickly as possible. Below you can find a non-exhaustive list of cancer diseases for which we are developing cures. If you can’t find your disease type among this list, we urge you to contact us, as our treatment method is very individualized and we may have treatment options for you.
|
Clinical Leadership
Co-Director, Developmental Therapeutics - Lurie Cancer Center
Director, Developmental Therapeutics Fellowship Associate Professor, Northwestern Feinberg School of Medicine Co-Director, Developmental Therapeutics - Lurie Cancer Center Associate Director, Developmental therapeutics Fellowship Assistant Professor, Northwestern Feinberg School of Medicine |